Singular Health Group Ltd (ASX: SHG) has unveiled the full integration of the Virtual Surgical Planning (VSP) software acquired in early 2021, to create a collaborative real-time Virtual Reality and 3D environment for visualising, collaborating, and designing patient specific components using medical data.
The company has begun beta testing its 3Dicom Lite (Web Edition) software with full 3D collaboration capabilities, aligning both the software and the company with the recently announced metaverse initiative from Meta Platforms Inc, Facebook’s parent company.
With the company having a core focus on Virtual Reality since the first version of MedVR was developed in 2017, the recent announcement of the metaverse initative by Meta Platforms Inc has brought into focus the scalable, globally accessible telemedicine and tele- consultation applications being developed by Singular Health. The 3Dicom suite of software provides the possibility for patient-practitioner consults while viewing a virtual twin of the patient’s anatomy and allows medical practitioners to collaboratively plan cases and design patient specific parts.
For the past two years, Singular Health has been using some of the essential components that ultimately comprise the metaverse including Virtual Reality (VR), collaboration, and Artificial Intelligence (AI).
In addition, Singular Health has been part of the Oculus Independent Software Vendor (ISV) programme since 2019 and the recent operational focus on the integration of VSP into the wireless Oculus Quest 2 VR headset provides the Company’s VR software with global scale and a proven third-party supply chain for ordering, delivery, and setup. Oculus is also owned by Meta Platforms Inc.
While much of the attention of the metaverse has focused on Virtual Reality, the Company’s development team has also built collaboration tools into its full suite of 3Dicom viewer tools including its recent release of 3Dicom Lite (Web Version).
This online version of 3Dicom Lite enables an enterprise deployment of Singular’s 3Dicom software. This deployment can be on local servers or delivered as a full Software as a Service (SaaS) model using HIPAA- compliant1cloud servers.
Granted in 2019, the vompany’s original patent 2019101736: Medical Virtual Reality and Mixed Reality Collaboration Platform, demonstrates that not only has Singular Health’s focus been for a number of years now on core elements of the metaverse, but also that the company has taken steps to protect and promote its vision of medical and health related collaboration through visualisation and manipulation of medical data in 3D and VR rendered representations of CT, MRI, and PET scans. As a result, collaborative voice & text chat features are being integrated into most of the 3Dicom Suite including 3Dicom Surgical on desktop devices. This will allow for fully interactive and collaborative telemedicine, visualisation, and multi-disciplinary discussions between medical practitioners globally.
Singular Health welcomes the attention to the metaverse by the recent announcements made by Meta Platfoms Inc. as it further validates both the technical and commercial vision on which the Company was built. The Company’s founder recognised the importance of collaboration in the virtual space in 2017 when he filed the Company’s original patent, and the recent release of the Meta’s Oculus Quest 2 VR headset has further allowed Singular Health to realise his vision,” Thomas Hanly, Singular Health’s CE), said.
“In addition to improved surgical planning, the development of VSP and 3Dicom Lite (Web Version) represents a key strategic step into providing medical decision support tools in telemedicine and give practitioners and their patients information that is secure, clear, and easy to understand.
“It is a credit to the Company’s staff that the VSP code is now fully integrated into 3Dicom, along with many associated collaborative voice and text features.”
